Onyx Healthcare (ROCO:6569) Ending Cash Position: NT$261 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:6569 Onyx Healthcare Inc ROCO:6569
73 GF Score
Price NT$90.70
GF Value NT$134.67
Valuation Significantly Undervalued
! 4 Warning Signs
View Full Analysis

What is Onyx Healthcare Ending Cash Position?

Onyx Healthcare ROCO:6569 -0.33% 73 Ending Cash Position is NT$261 Mil as of Jun. 2026. GuruFocus rates ROCO:6569 with a GF Score™ of 73/100 and a GF Value™ of NT$134.67 (Significantly Undervalued). The stock has 4 warning signs investors should review.

Onyx Healthcare's Ending Cash Position for the quarter that ended in Jun. 2026 was NT$261 Mil.

Onyx Healthcare's quarterly Ending Cash Position declined from Dec. 2025 (NT$374 Mil) to Mar. 2026 (NT$238 Mil) but then increased from Mar. 2026 (NT$238 Mil) to Jun. 2026 (NT$261 Mil).

Onyx Healthcare's annual Ending Cash Position declined from Dec. 2023 (NT$367 Mil) to Dec. 2024 (NT$325 Mil) but then increased from Dec. 2024 (NT$325 Mil) to Dec. 2025 (NT$374 Mil).

Onyx Healthcare Ending Cash Position Related Terms

Onyx Healthcare Ending Cash Position Historical Data

* Premium members only.

The historical data trend for Onyx Healthcare's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Onyx Healthcare Ending Cash Position Chart

Onyx Healthcare Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 182.89 328.89 366.77 324.59 374.34

Onyx Healthcare Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 372.94 321.95 374.34 238.05 260.77
ROCO:6569
73GF Score
Onyx Healthcare Inc ROCO:6569
Ending Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Onyx Healthcare Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Onyx Healthcare's Ending Cash Position for the fiscal year that ended in Dec. 2025 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=324.593+49.746
=374

Onyx Healthcare's Ending Cash Position for the quarter that ended in Jun. 2026 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=238.046+22.727
=261

Frequently Asked Questions Learn more about Ending Cash Position →
What does a Ending Cash Position of NT$261 Mil mean?
Onyx Healthcare (ROCO:6569) has a Ending Cash Position of NT$261 Mil as of Jun. 2026. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Onyx Healthcare and its competitors.
Is Onyx Healthcare's Ending Cash Position too high?
Onyx Healthcare's current Ending Cash Position is NT$261 Mil. Overall, Onyx Healthcare has a GF Score™ of 73/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Onyx Healthcare's Ending Cash Position compare to VEEV and BTSG?
Onyx Healthcare's Ending Cash Position of NT$261 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Ending Cash Position for a Healthcare Providers & Services company?
A good Ending Cash Position depends on the Healthcare Providers & Services industry context. However, Ending Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Ending Cash Position mean?
A high Ending Cash Position can signal that a stock is expensive relative to its fundamentals. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Onyx Healthcare and its competitors. Onyx Healthcare's current Ending Cash Position is NT$261 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Onyx Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Onyx Healthcare (ROCO:6569) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$134.67, compared to a current price of NT$90.70 — trading 32.7% below its estimated fair value. The current Ending Cash Position is NT$261 Mil. Onyx Healthcare's overall GF Score™ is 73/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Ending Cash Position calculated?
Ending Cash Position is calculated from a company's financial statements. For Onyx Healthcare (ROCO:6569), the current Ending Cash Position is NT$261 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Onyx Healthcare (ROCO:6569) Overvalued in 2026?

Based on GuruFocus' analysis, Onyx Healthcare stock appears to be undervalued. The current stock price of NT$90.70 is trading 32.7% below its estimated GF Value™ of NT$134.67. GuruFocus considers Onyx Healthcare to be Significantly Undervalued.

Key valuation signals for ROCO:6569:

  • Ending Cash Position: NT$261 Mil
  • GF Value™: NT$134.67 vs. price of NT$90.70 (32.7% below fair value)
  • GF Score™: 73/100 with 4 warning signs

No single metric tells the full story. See the ROCO:6569 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Onyx Healthcare Business Description

Address No. 135, Lane 235, Baoqiao Road, 4th Floor, Xindian District, New Taipei, TWN, 231028
Onyx Healthcare Inc is engaged in designing, manufacturing, and trading of medical computers and peripherals. The company provides medical products such as AI Ready Medical PC and Tablet, Medical PC & Monitor for Digital OR (ACCEL), Telemedicine, Medical Cart Computer(Venus), Medical Power Panel PC (Mini Venus), Power Bank (UPower), Battery Management System (ORION), Mobile Medical Tablet (MD), Professional Medical All in One PC (ZEUS), etc. It operates in Taiwan, the United States, Europe, and Other countries and generates maximum revenue from Taiwan.
73GF Score

Get the complete analysis for ROCO:6569

Ending Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$90.70
Price
NT$134.67
GF Value